换一批Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.
第一作者：
Giuseppe,Viale
第一单位：
Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan, Italy. giuseppe.viale@ieo.it
作者：
医学主题词
抗肿瘤药(Antineoplastic Agents);抗肿瘤药, 激素(Antineoplastic Agents, Hormonal);乳腺肿瘤(Breast Neoplasms);化学疗法, 辅助(Chemotherapy, Adjuvant);队列研究(Cohort Studies);内分泌系统(Endocrine System);女(雌)性(Female);人类(Humans);Ki-67抗原(Ki-67 Antigen);腈类(Nitriles);绝经后期(Postmenopause);试验预期值(Predictive Value of Tests);预后(Prognosis);比例危险度模型(Proportional Hazards Models);他莫昔芬(Tamoxifen);三唑类(Triazoles)
DOI
10.1200/JCO.2008.17.0829
PMID
18981464
发布时间
2025-04-28
- 浏览119
Journal of clinical oncology
5569-75页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
